s6y

CytoMed Therapeutics Ltd

Ticker
GDTC
CIK
1873093
Industry
Pharmaceutical Preparations
Formerly
CytoMed Therapeutics Pte. Ltd.

Ownership 27

  1. 4/A Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. SC 13G/A Major Shareholders

All 27 ownership filings

Prospectus 12

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  4. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  5. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  6. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  7. DRSLTR Correspondence Related to Draft Registration Statement
  8. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  9. DRSLTR Correspondence Related to Draft Registration Statement
  10. DRSLTR Correspondence Related to Draft Registration Statement

All 12 prospectus filings

Other 93

  1. SCHEDULE 13G/A
  2. SCHEDULE 13D/A
  3. SCHEDULE 13D/A
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 144 Filing for proposed sale of securities under Rule 144
  7. SCHEDULE 13D/A
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 93 other filings